Indication
Details coming soon
Details coming soon
| Clinical Information | Administration Information |
|---|---|
|
Indication: Primary immunisation Age: infants from 6 weeks to less than 6 months |
Dose: Injection – 0.5 ml Frequency: two doses Note: administered with an interval of 2 months between doses. |
|
Indication: Primary immunisation Age: infants from 6 months of age, children, adolescents and adults |
Dose: Injection – 0.5 mL Frequency: single dose |
| Clinical Information | Administration Information |
|---|---|
|
Indication: Meningococcal Vaccination Age: Infants from 6 weeks to less than 6 months |
Dose: Vaccine – 0.5 mL Frequency: two doses Note: should be administered with an interval of 2 months between doses |
|
Indication: Meningococcal Vaccination Age: Infants from 6 months of age, children, and adolescents |
Dose: Vaccine – 0.5 mL Frequency: single dose |
| Drug Name | Risk Factors |
|---|---|
|
Live vaccines
|
Interaction noted, but effect not specified
|
|
Immunosuppresants
|
Reduced immunological response
|
| Disease Name | Risk Factors |
|---|---|
|
Severe allergic reaction history
|
Risk of anaphylaxis
|
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.